272 related articles for article (PubMed ID: 29959999)
1. Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments.
Roggli VL
Toxicol Appl Pharmacol; 2018 Dec; 361():14-17. PubMed ID: 29959999
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
3. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
Garabrant DH; Pastula ST
Toxicol Appl Pharmacol; 2018 Dec; 361():127-136. PubMed ID: 30077661
[TBL] [Abstract][Full Text] [Related]
4. Measurement of elongate mineral particles: What we should measure and how do we do it?
Chatfield EJ
Toxicol Appl Pharmacol; 2018 Dec; 361():36-46. PubMed ID: 30134140
[TBL] [Abstract][Full Text] [Related]
5. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
Dufresne A; Harrigan M; Massé S; Bégin R
Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of murine alveolar macrophages to elongate mineral particles of asbestiform and non-asbestiform varieties: Cytotoxicity, cytokine secretion and transcriptional changes.
Khaliullin TO; Kisin ER; Guppi S; Yanamala N; Zhernovkov V; Shvedova AA
Toxicol Appl Pharmacol; 2020 Dec; 409():115302. PubMed ID: 33148505
[TBL] [Abstract][Full Text] [Related]
7. Toxicological and epidemiological approaches to carcinogenic potency modeling for mixed mineral fiber exposure: the case of fibrous balangeroite and chrysotile.
Korchevskiy AA; Wylie AG
Inhal Toxicol; 2023; 35(7-8):185-200. PubMed ID: 37220304
[TBL] [Abstract][Full Text] [Related]
8. Asbestiform fibers and cleavage Fragments: Conceptual approaches for differentiation in laboratory practice and data analysis.
Chatfield EJ
Environ Res; 2023 Aug; 230():114529. PubMed ID: 36965795
[TBL] [Abstract][Full Text] [Related]
9. Electron microscopy analysis of mineral fibers in human lung tissue.
Friedrichs KH; Brockmann M; Fischer M; Wick G
Am J Ind Med; 1992; 22(1):49-58. PubMed ID: 1329506
[TBL] [Abstract][Full Text] [Related]
10. Differentiating non-asbestiform amphibole and amphibole asbestos by size characteristics.
Harper M; Lee EG; Doorn SS; Hammond O
J Occup Environ Hyg; 2008 Dec; 5(12):761-70. PubMed ID: 18828048
[TBL] [Abstract][Full Text] [Related]
11. An updated review of diffuse mesothelioma of the pleura - A sentinel health event of potential elongate mineral particle pathogenicity.
Smith SR
Environ Res; 2023 Aug; 230():115608. PubMed ID: 36965792
[TBL] [Abstract][Full Text] [Related]
12. An inter-laboratory study to determine the effectiveness of procedures for discriminating amphibole asbestos fibers from amphibole cleavage fragments in fiber counting by phase-contrast microscopy.
Harper M; Lee EG; Slaven JE; Bartley DL
Ann Occup Hyg; 2012 Jul; 56(6):645-59. PubMed ID: 22456032
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary fibrosis in workers exposed to non-asbestiform tremolite asbestos minerals.
Yang HY; Shie RH; Chen PC
Epidemiology; 2013 Jan; 24(1):143-9. PubMed ID: 22983200
[TBL] [Abstract][Full Text] [Related]
14. The effect of weathering on ecopersistence, reactivity, and potential toxicity of naturally occurring asbestos and asbestiform minerals.
Enrico Favero-Longo S; Turci F; Tomatis M; Compagnoni R; Piervittori R; Fubini B
J Toxicol Environ Health A; 2009; 72(5):305-14. PubMed ID: 19184746
[TBL] [Abstract][Full Text] [Related]
15. Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation.
Roggli VL; Carney JM; Sporn TA; Pavlisko EN
Ultrastruct Pathol; 2020 Mar; 44(2):211-218. PubMed ID: 32183579
[TBL] [Abstract][Full Text] [Related]
16. Empirical model of mesothelioma potency factors for different mineral fibers based on their chemical composition and dimensionality.
Korchevskiy A; Rasmuson JO; Rasmuson EJ
Inhal Toxicol; 2019 Apr; 31(5):180-191. PubMed ID: 31328588
[No Abstract] [Full Text] [Related]
17. Dimensions of elongated mineral particles: a study of more than 570 fibers from more than 90 cases with implications for pathogenicity and classification as asbestiform vs. cleavage fragments.
Roggli VL; Green CL
Ultrastruct Pathol; 2019; 43(1):1-5. PubMed ID: 30668206
[TBL] [Abstract][Full Text] [Related]
18. Mesothelioma and asbestos.
Gibbs GW; Berry G
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S223-31. PubMed ID: 18022298
[TBL] [Abstract][Full Text] [Related]
19. Dimensions of elongate mineral particles and cancer: A review.
Wylie AG; Korchevskiy AA
Environ Res; 2023 Aug; 230():114688. PubMed ID: 36965798
[TBL] [Abstract][Full Text] [Related]
20. Lung asbestos content in chrysotile workers with mesothelioma.
Churg A; Wiggs B; Depaoli L; Kampe B; Stevens B
Am Rev Respir Dis; 1984 Dec; 130(6):1042-5. PubMed ID: 6095707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
